Phargomed El Salvador
WhatsApp
(3aR,8aR)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-2,2-bis(4-fluorophenyl)-6-hydroxy-tetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine, 98%, (99% ee)

Strem Chemicals

(3aR,8aR)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-2,2-bis(4-fluorophenyl)-6-hydroxy-tetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine, 98%, (99% ee)

N° de parte: 15-8625

Ligands | Catalysts | Other Reagents

Cotizar por WhatsApp
El producto (3aR,8aR)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-2,2-bis(4-fluorophenyl)-6-hydroxy-tetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine, 98%, (99% ee) de la marca Strem Chemicals, es un reactivo especializado que se utiliza principalmente como ligando en diversas reacciones químicas, específicamente en la catálisis. Este compuesto es de particular interés para laboratorios de investigación, universidades y clínicas que requieren de reactivos de alta pureza para sus estudios y experimentos. Al contar con un 98% de pureza y un 99% de enantioselectividad, es ideal para aplicaciones en síntesis orgánica y química medicinal, donde la precisión y la calidad del reactivo son fundamentales para el éxito de los procesos. Phargomed El Salvador distribuye la marca Strem Chemicals, asegurando entrega en todo El Salvador y brindando soporte local. Se invita a solicitar cotización en dólares a través de WhatsApp.

Productos relacionados

(11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-2-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee)

(11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-2-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee)

(11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee)

(11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee)

(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis[2,4,6-tricyclohexylphenyl]-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%

(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis[2,4,6-tricyclohexylphenyl]-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%

(11aR)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee)

(11aR)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee)

(11aR)-3,7-Bis(4-nitrophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee)

(11aR)-3,7-Bis(4-nitrophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee)

(11aR)-3,7-Di-9-anthracenyl-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 95%, (99% ee)

(11aR)-3,7-Di-9-anthracenyl-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 95%, (99% ee)